# L2 DIAGNOSTICS, LLC: A novel therapeutic, L2ASOCLE, for treating cutaneous lupus erythematosus (CLE)

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | L2 DIAGNOSTICS, LLC |
| Location | NEW HAVEN, CT |
| Project | A novel therapeutic, L2ASOCLE, for treating cutaneous lupus erythematosus (CLE) |
| Project number | 1R41AR087258-01A1 |
| Mechanism | R41 |
| Institute | National Institute of Arthritis and Musculoskeletal and Skin Diseases |
| Award | $323,090 |
| Awarded | 2026-09-19 |
| Project period | 2026-09-21 to 2027-08-31 |
| UEI | GKA7VH5LFR25 |

## Why this score
- Award of $323,090.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409672). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.